| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,620 |
12,742 |
$4.18M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,504 |
7,204 |
$3.72M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,213 |
2,017 |
$3.19M |
| G0378 |
Hospital observation service, per hour |
2,483 |
1,979 |
$2.59M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,317 |
3,698 |
$2.57M |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,818 |
2,474 |
$1.74M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,028 |
7,379 |
$1.04M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,962 |
5,226 |
$950K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,991 |
3,495 |
$912K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,994 |
4,651 |
$722K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,586 |
4,753 |
$609K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,023 |
900 |
$600K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,168 |
1,430 |
$576K |
| 71046 |
Radiologic examination, chest; 2 views |
4,207 |
3,723 |
$573K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
587 |
546 |
$421K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,716 |
2,680 |
$418K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,246 |
3,785 |
$349K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,789 |
5,688 |
$349K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,307 |
1,016 |
$294K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,449 |
3,533 |
$261K |
| 71045 |
Radiologic examination, chest; single view |
2,095 |
1,799 |
$242K |
| 96376 |
|
1,936 |
1,601 |
$175K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,187 |
366 |
$168K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
298 |
266 |
$165K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,853 |
4,904 |
$151K |
| J3490 |
Unclassified drugs |
10,299 |
4,307 |
$148K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,675 |
2,100 |
$140K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
881 |
607 |
$140K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
865 |
795 |
$139K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
960 |
493 |
$138K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
105 |
98 |
$129K |
| 87631 |
|
1,103 |
987 |
$125K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,800 |
1,506 |
$111K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
19,124 |
14,529 |
$103K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
426 |
394 |
$90K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
83 |
79 |
$87K |
| 80053 |
Comprehensive metabolic panel |
10,211 |
7,943 |
$76K |
| 80047 |
|
7,140 |
5,766 |
$60K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
610 |
555 |
$55K |
| 84484 |
|
6,765 |
4,318 |
$49K |
| J2704 |
Injection, propofol, 10 mg |
3,637 |
2,369 |
$42K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
765 |
640 |
$42K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
286 |
263 |
$34K |
| 83880 |
|
1,577 |
1,359 |
$33K |
| 80076 |
|
6,196 |
5,234 |
$32K |
| 83690 |
|
6,545 |
5,394 |
$32K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,582 |
2,308 |
$31K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,782 |
1,305 |
$29K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,769 |
2,368 |
$28K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,764 |
2,968 |
$28K |
| 84703 |
|
4,454 |
3,868 |
$28K |
| 83735 |
|
6,095 |
4,748 |
$28K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,758 |
1,258 |
$27K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
342 |
108 |
$27K |
| 83605 |
|
3,533 |
2,774 |
$26K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,123 |
1,745 |
$23K |
| 80305 |
|
2,542 |
2,218 |
$23K |
| 96367 |
|
341 |
250 |
$21K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,316 |
2,527 |
$20K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,409 |
1,715 |
$19K |
| 73610 |
|
115 |
103 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,734 |
2,294 |
$15K |
| 97535 |
Self-care/home management training, each 15 minutes |
272 |
167 |
$15K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,173 |
1,646 |
$15K |
| 87040 |
|
1,431 |
994 |
$15K |
| 81001 |
|
6,376 |
5,514 |
$14K |
| 76857 |
|
73 |
64 |
$14K |
| J2060 |
Injection, lorazepam, 2 mg |
1,657 |
1,199 |
$14K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,243 |
2,004 |
$13K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
662 |
501 |
$13K |
| 82803 |
|
786 |
662 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
308 |
291 |
$11K |
| 73030 |
|
70 |
63 |
$11K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
27 |
24 |
$11K |
| 59050 |
|
38 |
27 |
$11K |
| 73630 |
|
82 |
70 |
$11K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
18 |
13 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
301 |
284 |
$9K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
558 |
408 |
$9K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,422 |
974 |
$9K |
| G0379 |
Direct admission of patient for hospital observation care |
39 |
29 |
$9K |
| 73562 |
|
48 |
44 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
226 |
211 |
$8K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
226 |
211 |
$8K |
| 82805 |
|
173 |
129 |
$7K |
| 87186 |
|
1,019 |
955 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
83 |
37 |
$7K |
| 86141 |
|
630 |
525 |
$7K |
| 82310 |
|
1,956 |
1,769 |
$6K |
| J7050 |
Infusion, normal saline solution, 250 cc |
326 |
144 |
$6K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
17 |
12 |
$6K |
| 82962 |
|
2,479 |
1,481 |
$6K |
| 85610 |
|
2,099 |
1,751 |
$6K |
| 73130 |
|
30 |
25 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
9,440 |
7,122 |
$4K |
| 80051 |
|
833 |
722 |
$4K |
| 86318 |
|
242 |
232 |
$3K |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
688 |
311 |
$3K |
| C9113 |
Injection, pantoprazole sodium, per vial |
313 |
254 |
$3K |
| 82565 |
|
869 |
749 |
$3K |
| 86140 |
|
776 |
638 |
$3K |
| 81003 |
|
1,803 |
1,606 |
$3K |
| 85027 |
|
585 |
461 |
$3K |
| 82947 |
|
852 |
740 |
$2K |
| 84520 |
|
868 |
749 |
$2K |
| 85379 |
|
313 |
292 |
$2K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
50 |
28 |
$2K |
| 73110 |
|
14 |
12 |
$2K |
| 87070 |
|
272 |
244 |
$2K |
| 97162 |
|
44 |
40 |
$2K |
| 90715 |
|
69 |
66 |
$2K |
| 86850 |
|
283 |
241 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
208 |
180 |
$1K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
106 |
65 |
$1K |
| 94664 |
|
16 |
14 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
249 |
159 |
$1K |
| 12001 |
|
14 |
13 |
$1K |
| 80061 |
Lipid panel |
108 |
97 |
$1K |
| 10060 |
|
13 |
12 |
$957.96 |
| 86901 |
|
487 |
413 |
$891.97 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
224 |
182 |
$819.47 |
| G9035 |
Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project) |
21 |
17 |
$654.94 |
| 86900 |
|
332 |
283 |
$584.02 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
33 |
27 |
$500.87 |
| 87205 |
|
144 |
123 |
$493.38 |
| 84439 |
|
68 |
64 |
$431.65 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
72 |
58 |
$408.23 |
| 85651 |
|
128 |
116 |
$381.41 |
| 84702 |
|
16 |
12 |
$286.01 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
45 |
29 |
$244.37 |
| 87077 |
|
30 |
26 |
$169.68 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
18 |
16 |
$153.92 |
| J3480 |
Injection, potassium chloride, per 2 meq |
25 |
12 |
$130.28 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
3,903 |
3,034 |
$124.25 |
| 87147 |
|
27 |
25 |
$121.41 |
| 85730 |
|
34 |
28 |
$101.87 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
31 |
29 |
$98.40 |
| 82374 |
|
24 |
23 |
$92.31 |
| 84295 |
|
24 |
23 |
$90.95 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
41 |
38 |
$90.07 |
| 84436 |
|
15 |
14 |
$88.14 |
| 84132 |
|
24 |
23 |
$86.87 |
| 82435 |
|
24 |
23 |
$86.87 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
51 |
36 |
$77.61 |
| 84479 |
|
14 |
13 |
$76.10 |
| 82248 |
|
16 |
14 |
$72.41 |
| A9270 |
Non-covered item or service |
50,617 |
15,965 |
$63.93 |
| 87210 |
|
14 |
13 |
$52.09 |
| 87088 |
|
12 |
12 |
$49.95 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
17 |
12 |
$18.16 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
40 |
37 |
$0.00 |
| 0353U |
|
12 |
12 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
174 |
156 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
41 |
27 |
$0.00 |
| J3535 |
Drug administered through a metered dose inhaler |
95 |
86 |
$0.00 |
| 80320 |
|
22 |
16 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
47 |
27 |
$0.00 |